About Equilibrative nucleoside transporter 3
Equilibrative nucleoside transporter 3 (SLC29A3) is a protein
from Homo sapiens identified by UniProt accession
Q9BZD2, 475 residues long.
MolForge cross-references it against 0 known binders and
283 disease associations.
Target properties
| Protein name | Equilibrative nucleoside transporter 3 |
| UniProt accession | Q9BZD2 |
| Gene | SLC29A3 |
| Organism | Homo sapiens |
| Length | 475 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (283)
Diseases linked to this target (Open Targets).
- H syndrome · score 0.84
- neurodegenerative disease · score 0.44
- lymphocyte count · score 0.42
- dysosteosclerosis · score 0.38
- Disorder of amino acid and other organic acid metabolism · score 0.37
- acanthosis nigricans · score 0.33
- myeloid white cell count · score 0.31
- neuritic plaque measurement · score 0.31
- leukocyte count · score 0.28
- genetic disorder · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BZD2-F1 | alphafold | PREDICTED | 82.33 | — |
Amino-acid sequence (475 residues)
MAVVSEDDFQ HSSNSTYRTT SSSLRADQEA LLEKLLDRPP PGLQRPEDRF CGTYIIFFSL GIGSLLPWNF FITAKEYWMF KLRNSSSPAT GEDPEGSDIL NYFESYLAVA STVPSMLCLV ANFLLVNRVA VHIRVLASLT VILAIFMVIT ALVKVDTSSW TRGFFAVTIV CMVILSGAST VFSSSIYGMT GSFPMRNSQA LISGGAMGGT VSAVASLVDL AASSDVRNSA LAFFLTATVF LVLCMGLYLL LSRLEYARYY MRPVLAAHVF SGEEELPQDS LSAPSVASRF IDSHTPPLRP ILKKTASLGF CVTYVFFITS LIYPAICTNI ESLNKGSGSL WTTKFFIPLT TFLLYNFADL CGRQLTAWIQ VPGPNSKALP GFVLLRTCLI PLFVLCNYQP RVHLKTVVFQ SDVYPALLSS LLGLSNGYLS TLALLYGPKI VPRELAEATG VVMSFYVCLG LTLGSACSTL LVHLI
Explore Equilibrative nucleoside transporter 3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets